Defactinib (Compound)

Synonyms:Defactinib, 1073154-85-4, PF-04554878, VS-6063, 1345713-71-4, UNII-53O87HA2QU, Defactinib (VS-6063, PF-04554878), 53O87HA2QU, N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide, N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide, VS 6063, Benzamide, N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)-2-pyrazinyl)methyl)amino)-5-(trifluoromethyl)-2-pyrimidinyl)amino)-, VS6063, Defactinib [USAN:INN], Defactinib (USAN/INN), GTPL7910, SCHEMBL1627234, C20H21F3N8O3S, CHEMBL3137331, Defactinib (PF-04554878), BDBM418817, HMS3740O13, AMY42170, AOB87723, BCP11299, EX-A1037, EX-A1049, 2361AH, MFCD25977806, NSC778364, NSC781450, NSC782549, NSC800089, s7654, US10450297, Example 317, US10450297, Example 318, AKOS026750300, ZINC103297739, CCG-269780, CS-3410, DB12282, NSC-778364, NSC-781450, NSC-782549, NSC-800089, SB17060, NCGC00386425-06, NCGC00386425-11, AS-17045, DA-34914, DA-45890, HY-12289, FT-0706351, FT-0721609, J3.502.756D, PF 04554878, D10618, A887883, J-690021, Q27077009, 7KD, N-Methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide, N-methyl-4-((4-(((3-methyl(methylsulfonyl)aminopyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide, N-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]pyrazin-2- yl}methyl)amino]-5- (trifluoromethyl)pyrimidin-2- yl}amino)benzamide (317), N-methyl-4-(4-((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)benzamide

Pubchem:PUBCHEM:25117126

Id:25117126

Description:nan